Ase H. Morsund
Molde, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis.
Journal: The New England journal of medicine
Published: July 01, 2026
Brain MRI findings in patients with post COVID-19 condition: frequency and longitudinal changes in a nationwide cohort study.
Journal: Frontiers in neurology
Published: July 08, 2025
Tenecteplase in Central Retinal Artery Occlusion Study (TenCRAOS): Protocol for a randomized-controlled trial.
Journal: European stroke journal
Published: June 13, 2025
Amyotrophic lateral sclerosis caused by the C9orf72 expansion in Norway - prevalence, ancestry, clinical characteristics and sociodemographic status.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: September 24, 2024
Genetic Epidemiology of Amyotrophic Lateral Sclerosis in Norway: A 2-Year Population-Based Study.
Journal: Neuroepidemiology
Published: March 15, 2022
Factors influencing employment after minor stroke and NSTEMI.
Journal: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
Published: November 05, 2019
The development of cognitive and emotional impairment after a minor stroke: A longitudinal study.
Journal: Acta neurologica Scandinavica
Published: January 28, 2019
Cognitive and Emotional Impairment after Minor Stroke and Non-ST-Elevation Myocardial Infarction (NSTEMI): A Prevalence Study.
Journal: Stroke research and treatment
Published: December 04, 2018
Stroke risk after transient ischemic attack in a Norwegian prospective cohort.
Journal: BMC neurology
Published: July 28, 2018
Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial.
Journal: The Lancet. Neurology
Published: May 14, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026